乳腺癌患者随访策略探讨

摘要
图/表
参考文献(32)
相关文章 (15)

全文: PDF (899 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要乳腺癌是女性常见的恶性肿瘤之一，发病人数多、预后良好等乳腺癌疾病特点使随访成为乳腺癌患者管理的重要环节。了解随访策略的研究进展有助于我们更好地开展随访工作，随访依从性差可能与治疗后不同时间段、不同地区、不同年龄、不同治疗方式相关，个体化随访可能成为乳腺癌患者随访管理趋势，同时随访中应添加更多的心理干预。本文基于乳腺癌随访的研究进展，就乳腺癌随访策略作一综述，为完善乳腺癌患者随访管理提供依据。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	冯然1 高晋南2 杨海波2

关键词 ：乳腺癌, 随访, 依从性, 钼靶, 乳腺彩超, 个体化随访

Abstract：Breast cancer is a most common malignancy of women. The characteristics of breast cancer, such as high incidence and good prognosis, make follow-up an important part of breast cancer management. Knowing about current progress will help us to carry out better follow-up strategies. The adherence to follow-up may be related to different patients characteristics, living area, age groups and treatment regimen. Individualized follow-up strategy has become a trend for breast cancer patients′ follow-up management. Meanwhile, more psychological interventions should be added to the work. This article reviews the current breast cancer follow-up strategies and will benefit for the long-time management of breast cancer patients.

Key words： Breast cancer Follow-up Adherence Mammography Ultrasonography Individualized follow-up

基金资助:山西省科技厅基金项目（2018041032-2）。

通讯作者: 高晋南（1964.2-），男，博士，主任医师，山西医科大学附属大医院乳腺外科主任；研究方向：乳腺癌流行病学研究。

作者简介: 冯然（1994.8-），女，山西医科大学附属大医院2017级外科学专业在读硕士研究生；研究方向：普通外科（乳腺外科）。

引用本文:

冯然1 高晋南2 杨海波2. 乳腺癌患者随访策略探讨[J]. 中国医药导报, 2019, 16(33): 40-42,54.
FENG Ran1 GAO Jinnan2 YANG Haibo2. Discussion on follow-up strategy of breast cancer patients. 中国医药导报, 2019, 16(33): 40-42,54.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2019/V16/I33/40

[1] 马飞，徐兵河，邵志敏，等.乳腺癌随访及伴随疾病全方位管理指南[J].中华肿瘤杂志，2019，41（1）：29-41.
[2] 王新民，周汉新，曹海波.我国开展病人随访工作的紧迫感与国内外进展[J].中国卫生质量管理，2006，13（6）：41-43.
[3] Chen W，Zheng R，Baade PD. Cancer statistics in China，2015 [J]. CA Cancer J Clin，2016，66（2）：115-132.
[4] Waks AG，Winer EP. Breast Cancer Treatment：A Review [J]. JAMA，2019，321（3）：288-300.
[5] Ruddy KJ，Sangaralingham L，Freedman RA，et al. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors [J]. J Natl Compr Canc Netw，2018，16（5）：526-534.
[6] Lu W，Jansen L，Schaapveld M，et al. Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? [J]. BMC Cancer，2011，11：279-285.
[7] Schapira MM，McAuliffe TL，Nattinger AB. Underutilization of mammography in older breast cancer survivors [J]. Med Care，2000，38（3）：281-289.
[8] Grunfeld E，Hodgson DC，Del Giudice ME，et al. Population-Based Longitudinal Study of Follow-Up Care for Breast Cancer Survivors [J]. J Oncol Pract，2010，6（4）：174-181.
[9] Keating NL，Landrum MB，Guadagnoli E，et al. Factors related to underuse of surveillance mammogrraphy among breast cancer survivors [J]. J Clin Oncol，2006，24（1）：85-94.
[10] Font R，Espinas JA，Barnadas A，et al. Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival：a population-based study in Catalonia，Spain [J]. Breast Cancer Res Treat，2019，175（3）：733-740.
[11] Lash TL，Fox MP，Buist DS，et al. Mammography surveillance and mortality in older breast cancer survivors [J]. J Clin Oncol，2007，25（21）：3001-3006.
[12] Ogawa Y，Ikeda K，Izumi T，et al. First indicators of relapse in breast cancer：evaluation of the follow-up program at our hospital [J]. Int J Clin Oncol，2013，18（3）：447-453.
[13] Ishitobi M，Fukui R，Hashimoto Y，et al. pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery [J]. Oncology，2018，94（1）：12-18.
[14] Kim SJ，Chung SY，Chang JM，et al. Ultrasound screening of contralateral breast after surgery for breast cancer [J]. Eur J Radiol，2015，84（1）：54-60.
[15] 朱思吉，沈坤炜.乳腺癌术后随访策略的现状与争议[J].中华外科杂志，2014，52（10）：790-793.
[16] Lafranconi A，Pylkk?覿nen L，Deandrea S，et al. Intensive follow-up for women with breast cancer：review of clinical，economic and patient′s preference domains through evidence to decision framework [J]. Health Qual Life Outcomes，2017，15（1）：206.
[17] The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial [J]. JAMA，1994，271（20）：1587-1592.
[18] Rosselli Del Turco M，Palli D，Cariddi A，et al. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up [J]. JAMA，1994，271（20）：1593-1597.
[19] Moschetti I，Cinquini M，Lambertini M，et al. Follow-up strategies for women treated for early breast cancer [J]. Cochrane Database Syst Rev，2016，（5）：CD001768.
[20] Sperduti I，Vici P，Tinari N，et al. Breast cancer follow-up strategies in randomized phase Ⅲ adjuvant clinical trials：a systematic review [J]. J Exp Clin Cancer Res，2013， 32：89-100.
[21] Risendal BC，Sedjo RL，Giuliano AR，et al. Surveillance and beliefs about follow-up care among long-term breast cancer survivors：a comparison of primary care and oncology providers [J]. J Cancer Surviv，2016，10（1）：96-102.
[22] Grandjean I，Kwast AB，de Vries H，et al. Evaluation of the adherence to follow-up care guidelines for women with breast cancer [J]. Eur J Oncol Nurs，2012，16（3）：281-285.
[23] Kim KS，Kim Z，Shim EJ，et al. The reality in the follow-up of breast cancer survivors：survey of Korean Breast Cancer Society [J]. Ann Surg Treat Res，2015，88（3）：133-139.
[24] Sopik V，Sun P，Narod SA. Predictors of time to death after distant recurrence in breast cancer patients [J]. Breast Cancer Res Treat，2019，173（2）：465-474.
[25] Yamazaki N，Wada N，Yamauchi C，et al. High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy [J]. Eur J Surg Oncol，2015，41（5）：617-624.
[26] Li J，Liu Y，Jiang Y，et al. Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods [J]. PLoS One，2016，11（6）：e0157322.
[27] 何咏竞，孙国平.乳腺癌术后复发时间与临床因素的相关性分析[J].临床外科杂志，2018，26（1）：35-38.
[28] Natoli C，Brocco D，Sperduti I，et al. Breast cancer “tailored follow-up” in Italian oncology units：a web-based survey [J]. PLoS One，2014，9（4）：e94063.
[29] Neuman HB，Weiss JM. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors [J]. Ann Surg Oncol，2013，20（13）：4128-4136.
[30] Enright K，Desai T，Sutradhar R，et al. Factors associated with imaging in patients with early breast cancer after initial treatment [J]. Curr Oncol，2018，25（2）：126-132.
[31] Stagl JM，Lechner SC，Carver CS，et al. A randomized controlled trial of cognitive-behavioral stress management in breast cancer：survival and recurrence at 11-year follow-up [J]. Breast Cancer Res Treat，2015，154（2）：319-328.
[32] Berendsen AJ，Roorda C，Jansen L，et al. Patients′ beliefs about the aims of breast cancer follow-up：A qualitative study [J]. Maturitas，2016，91：140-144.